Is Bone Biologics Corporation (BBLG) a Buy, Sell, or Hold?
Bone Biologics Corporation
NASDAQ:BBLG
$1.26 USD
-$0.04 (-3.08%)
- Volume
- 85.98K
- Average Volume
- 56.7K
- Market Capitalization
- $2.26M
- P/E Ratio
- -0.46
- Dividend Yield
- 0.00%
- Price Target
- $
- Year High
- $4.13
- Year Low
- $1.05
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $16.09
Industry, Sector & symbol
| Stock Exchange | NASDAQ |
| CEO | Jeffrey Frelick |
| Industry | Biotechnology |
| Sector | Healthcare |
| Current Symbol | BBLG |
| CUSIP | 098070600 |
| CIK | 0001419554 |
| Web | https://www.bonebiologics.com |
| Phone | 781 552 4452 |
| Currency | USD |
| Employees | 2 |
| Country | US |
Liquidity
| Debt-to-Equity Ratio | 0.00 |
| Payout Ratio | 0.00 |
| Current Ratio | 16.09 |
| Quick Ratio | 16.09 |
| Cash Ratio | 14.64 |
Sales & Book Value
| Annual Sales | $- |
| Price / Sales | 0.00 |
| Cash Flow | -1.43 |
| Price / Cash Flow | -0.88 |
| Price / Book | 0.48 |
Price Target and Rating
| Average Stock Price Forecast | $ |
| High Stock Price Forecast | $ |
| Low Stock Price Forecast | $ |
| Forecast Upside/Downside | % |
| Consensus Rating | Sell |
| Rating Score(0-5) | 2 |
| Research Coverage | 0 Analysts |
Profitability
| EPS (Most Recent Fiscal Year) | $-2.65 |
| Trailing P/E Ratio | -0.46 |
| PEG Ratio | -0.06 |
| P/E Growth | -0.06 |
| Net Income | $-3.11M |
| Net Margin | 0.00% |
| Pretax Margin | 0.00% |
| Return on Equity | -50.45% |
| Return on Assets | -57.40% |
Financials Score
| AltmanZ Score | -21.23 |
| Piotroski Score | 3.00 |
| Working Capital | 4.67M |
| Total Assets | 4.98M |
| Ebit | -2.85M |
| Market Cap | 2.33M |
| Total Liabilities | 309.39K |
Poll Results
About Bone Biologics Corporation (NASDAQ:BBLG) Stock
Bone Biologics Corporation, a medical device enterprise, specializes in fostering bone regeneration for spinal fusion, leveraging its advanced recombinant human protein technology. Its flagship product, NELL-1/DBX, is a unique combination of an osteostimulative recombinant protein designed for precise, targeted control over bone regrowth. The company is currently advancing the NELL-1/DBX Fusion Device, intended for spinal fusion interventions in skeletally mature individuals experiencing single-level degenerative disc disease within the L4-S1 spinal segments. This versatile platform technology also holds the potential to deliver superior outcomes across a wide spectrum of surgical specialties, including spinal, various orthopedic fields, plastic reconstruction, neurosurgery, interventional ... radiology, and sports medicine. Bone Biologics holds a licensing agreement with the UCLA Technology Development Group, which authorizes the development and commercialization of NELL-1 for its spinal fusion applications. The firm was established in 2004 and is based in Burlington, Massachusetts.
2026-07-07 20:00:00
$3.0 million upfront with up to approximately $6.0 million of potential additional gross proceeds upon the exercise in full of warrants in cash $3.0 million upfront with up to approximately $6.0 million of potential additional gross proceeds upon the exercise in full of warrants in cash
Frequently Asked Questions
-
What is the current Bone Biologics Corporation (BBLG) stock price?
-
Bone Biologics Corporation(NASDAQ:BBLG) stock price is $1.26 in the last trading session. During the trading session, BBLG stock reached the peak price of $4.13 while $1.05 was the lowest point it dropped to. The percentage change in BBLG stock occurred in the recent session was --3.08% while the dollar amount for the price change in BBLG stock was -$-0.04.
-
BBLG's industry and sector of operation?
-
The NASDAQ listed BBLG is part of Biotechnology industry that operates in the broader Healthcare sector.
-
Who are the executives of BBLG?
-
Jeffrey Frelick | Chief Executive Officer & President
Deina H. Walsh | Chief Financial Officer
|
|
| -
How many employees does BBLG have?
-
Number of BBLG employees currently stands at 2. BBLG operates from 2 Burlington Woods Drive, Burlington, MA 01803, US.
-
Link for BBLG official website?
-
Official Website of BBLG is: https://www.bonebiologics.com
-
How do I contact BBLG?
-
BBLG could be contacted at phone #781 552 4452 and can also be accessed through its website. BBLG operates from 2 Burlington Woods Drive, Burlington, MA 01803, US.
-
How many shares of BBLG are traded daily?
-
The average number of BBLG shares traded daily for last 3 months was 56.7K.
-
What is the market cap of BBLG currently?
-
The market value of BBLG currently stands at $2.26M with its latest stock price at $1.26